A Humanized Anti-Interferon-? Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease
A Phase II, Double-Blind, Placebo-Controlled Study to Determine the Safety and Efficacy of a Humanized Anti-Interferon-? Monoclonal Antibody (HuZAF) Administered to Patients With Moderate to Severe Crohn's Disease A Phase II, Double-Blind, Placebo-Controlled Study to Determine the Safety and Efficacy of a Humaniz ...
Crohn's Disease;Colitis;Intestinal Disease;Gastrointestinal Disease;Digestive System Disease